Indication
Hyperplasia
3 clinical trials
4 products
1 drug
Product
NaftopidilProduct
TamsulosinClinical trial
PHASE III, DOUBLE-BLIND, RANDOMIZED STUDY COMPARING THE EFFICACY AND SAFETY OF NAFTOPIDIL AND TAMSULOSIN TO TREATMENT THE SYMPTOMS OF LOWER URINARY TRACT IN PATIENTS WITH BENIGN PROSTATE HYPERPLASIAStatus: Withdrawn, Estimated PCD: 2011-09-01
Clinical trial
M4OC-Prevent: Metformin for Oral Cancer PreventionStatus: Active (not recruiting), Estimated PCD: 2017-10-12
Drug
MetforminClinical trial
Interval Bolus Delivery of Subcutaneous Hydrocortisone Via Infusion Pump in Children With Congenital Adrenal HyperplasiaStatus: Completed, Estimated PCD: 2023-02-23
Product
Hydrocortisone